MDS 2020 | Research in Parkinson’s disease: lysosomal dysfunction, immune response and antibodies

Tiago Outeiro, PhD, University Medical Center Göttingen, Göttingen, Germany, discusses three areas of research that have been translated from the lab into clinical trials. First, research understanding the biology of lysosomal dysfunction and its role in Parkinson’s disease, which could be a potential target for treatment. Second, the role of the immune system in Parkinson’s disease and how it can be targeted for therapeutic intervention. Finally, antibody-based therapies. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).